The ROE as of September 2024 (TTM) for Venus Concept Inc. (VERO) is 444.07%

According to Venus Concept Inc.’s latest financial reports and current stock price. The company's current ROE is 444.07%. This represents a change of -620.04% compared to the average of -85.39% of the last 4 quarters.

Venus Concept Inc. (VERO) Historical ROE (quarterly & annually)

How has VERO ROE performed in the past?

The mean historical ROE of Venus Concept Inc. over the last ten years is -276.46%. The current 444.07% ROE has changed -260.62% with respect to the historical average. Over the past ten years (40 quarters), VERO's ROE was at its highest in in the March 2023 quarter at 1.09%. The ROE was at its lowest in in the June 2018 quarter at -1035.49%.

Venus Concept Inc. (VERO) ROE by Quarter and Year

Discovering the peaks and valleys of Venus Concept Inc. ROE, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Venus Concept Inc. (VERO) Average ROE

How has VERO ROE performed in the past?

The current ROE of Venus Concept Inc. (VERO) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages

Venus Concept Inc. (VERO) ROE vs. Peers

How is VERO’s ROE compared to its peers?

Venus Concept Inc.’s ROE is less than Aziyo Biologics, Inc. (196.38%), greater than Ainos, Inc. (-64.53%), greater than Surmodics, Inc. (-1.16%), greater than LENSAR, Inc. (-30.16%), greater than IRIDEX Corporation (-134.37%), greater than CVRx, Inc. (-77.62%), greater than Inogen, Inc. (-45.37%), greater than Orthofix Medical Inc. (-20.68%), greater than Establishment Labs Holdings Inc. (-220.67%), greater than NeuroPace, Inc. (-195.26%), greater than Sight Sciences, Inc. (-45.68%), greater than STRATA Skin Sciences, Inc. (-69.56%), less than Vapotherm, Inc. (86.17%), greater than Talis Biomedical Corporation (-79.73%), greater than Bone Biologics Corporation (-154.16%), greater than Bluejay Diagnostics, Inc. (-187.00%), greater than Nuwellis, Inc. (-1671.56%), greater than Heart Test Laboratories, Inc. (-144.10%), less than Accelerate Diagnostics, Inc. (131.18%), greater than Anika Therapeutics, Inc. (-32.91%), greater than AxoGen, Inc. (-17.30%),

Build a custom stock screener for Venus Concept Inc. (VERO) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Venus Concept Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Venus Concept Inc. (VERO) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Venus Concept Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.